These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17697450)

  • 21. Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study.
    Gajria K; Kosinski M; Schein J; Kavanagh S; Dubois D
    Patient; 2008 Jul; 1(3):223-38. PubMed ID: 22272928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating health state utility values for comorbid health conditions using SF-6D data.
    Ara R; Brazier J
    Value Health; 2011; 14(5):740-5. PubMed ID: 21839413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric testing and validation of the Chronic Pain Sleep Inventory.
    Kosinski M; Janagap CC; Gajria K; Schein J
    Clin Ther; 2007; 29 Suppl():2562-77. PubMed ID: 18164922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.
    Brazier JE; Kolotkin RL; Crosby RD; Williams GR
    Value Health; 2004; 7(4):490-8. PubMed ID: 15449641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
    Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
    Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.
    Vernon MK; Brandenburg NA; Alvir JM; Griesing T; Revicki DA
    J Pain Symptom Manage; 2008 Jul; 36(1):54-68. PubMed ID: 18411009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-preference disability assessment for disabling chronic low back pain: a cross-sectional survey.
    Sanchez K; Papelard A; Nguyen C; Jousse M; Rannou F; Revel M; Poiraudeau S
    Spine (Phila Pa 1976); 2009 May; 34(10):1052-9. PubMed ID: 19363459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of patient-reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain.
    Cole JC; Dubois D; Kosinski M
    Clin Ther; 2007; 29 Suppl():2580-8. PubMed ID: 18164923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circumferential fusion is dominant over posterolateral fusion in a long-term perspective: cost-utility evaluation of a randomized controlled trial in severe, chronic low back pain.
    Soegaard R; Bünger CE; Christiansen T; Høy K; Eiskjaer SP; Christensen FB
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2405-14. PubMed ID: 18090078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
    Yang Q; Huang D; Jiang L; Tang Y; Zeng D
    Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health state utilities in latent and active tuberculosis.
    Guo N; Marra CA; Marra F; Moadebi S; Elwood RK; Fitzgerald JM
    Value Health; 2008 Dec; 11(7):1154-61. PubMed ID: 18489493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome.
    Roset M; Badia X; Forsythe A; Webb SM
    Patient; 2013; 6(2):103-11. PubMed ID: 23549927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Bayesian methods to model the SF-6D health state preference based data.
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.
    Yang Q; Jiang LL; Li YF; Huang D
    Health Qual Life Outcomes; 2023 Nov; 21(1):122. PubMed ID: 37964348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.